Pharmaceuticals Ultrasector Profund
Filed by ProFunds. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| AMLXAmylyx Pharmaceuticals Inc | 1.62% | $138.5K |
| NKTRNektar Therapeutics | 1.33% | $114.3K |
| BMYBristol-Myers Squibb Co | 1.26% | $107.8K |
| LGNDLigand Pharmaceuticals Inc | 1.24% | $106.4K |
| ELANElanco Animal Health Inc | 1.23% | $105.8K |
| PCRXPacira Biosciences Inc | 1.21% | $103.5K |
| VTRSViatris Inc | 1.19% | $102.2K |
| MRKMerck & Co Inc | 1.17% | $100.4K |
| JNJJohnson & Johnson | 1.15% | $98.7K |
| LLYEli Lilly and Co | 1.08% | $93.1K |
| OGNOrganon & Co | 1.08% | $93K |
| SUPNSupernus Pharmaceuticals Inc | 1.06% | $90.9K |
| PFEPfizer Inc | 1.05% | $89.7K |
| ZTSZoetis Inc | 1.02% | $87.3K |
| INVAInnoviva Inc | 0.98% | $83.7K |
| AXSMAxsome Therapeutics Inc | 0.95% | $81.3K |
| RLMDRelmada Therapeutics Inc | 0.57% | $48.8K |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow Pharmaceuticals Ultrasector Profund by email
Pharmaceuticals Ultrasector Profund's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.